wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38811530-1F6E8D0F-690C-4315-ABB6-D923AF4E00B7
Q38811530-1F6E8D0F-690C-4315-ABB6-D923AF4E00B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38811530-1F6E8D0F-690C-4315-ABB6-D923AF4E00B7
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
P2860
Q38811530-1F6E8D0F-690C-4315-ABB6-D923AF4E00B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38811530-1F6E8D0F-690C-4315-ABB6-D923AF4E00B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da3bd38698862a2071cf894e51b91c5dda60e38f
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).